These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21460320)

  • 1. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection.
    Herrera V; Perry S; Parsonnet J; Banaei N
    Clin Infect Dis; 2011 Apr; 52(8):1031-7. PubMed ID: 21460320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial testing of interferon-gamma-release assays for the diagnosis of latent tuberculosis in hemodialysis patients.
    Chung WK; Zheng ZL; Kim HS; Park JW; Lee HJ; Chang JH; Jeong JY; Kim S; Lee HH; Yang J
    J Infect; 2010 Jul; 61(2):144-9. PubMed ID: 20435059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting.
    Kardos M; Kimball AB
    J Am Acad Dermatol; 2012 Jan; 66(1):148-52. PubMed ID: 22177633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?
    Denkinger CM; Dheda K; Pai M
    Clin Microbiol Infect; 2011 Jun; 17(6):806-14. PubMed ID: 21682801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
    Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
    Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons.
    Santin M; Casas S; Saumoy M; Andreu A; Moure R; Alcaide F; Ferrer E; Podzamczer D
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):59-65. PubMed ID: 21146715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children.
    Lewinsohn DA; Lobato MN; Jereb JA
    Curr Opin Pediatr; 2010 Feb; 22(1):71-6. PubMed ID: 19952926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer.
    Stefan DC; Dippenaar A; Detjen AK; Schaaf HS; Marais BJ; Kriel B; Loebenberg L; Walzl G; Hesseling AC
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):689-94. PubMed ID: 20487605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
    Banaei N; Gaur RL; Pai M
    J Clin Microbiol; 2016 Apr; 54(4):845-50. PubMed ID: 26763969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
    Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
    Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.
    Dheda K; van Zyl Smit R; Badri M; Pai M
    Curr Opin Pulm Med; 2009 May; 15(3):188-200. PubMed ID: 19387262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Detjen AK; Keil T; Roll S; Hauer B; Mauch H; Wahn U; Magdorf K
    Clin Infect Dis; 2007 Aug; 45(3):322-8. PubMed ID: 17599309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.